DPP4 and ovarian dysfunction: In non-pregnant poor responders who were given sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and underwent ART, ovarian dysfunction was ameliorated, and ongoing pregnancy rates increased significantly, in those patients whose serum TAGE levels were decreased by the sitagliptin.